GSHP Summer Meeting Agenda

as of 4/28/2025

Program Key

General Session

Special Events

Date and Time 

Credit Hrs.

Topic 

Speaker

Thursday, July 10, 2025

3:00pm-5:00pm

Friday, July 11, 2025

7:00am-7:45am

Registration and Breakfast

8:00-9:00am 

1

Prescription for Precision: Measuring Success in Pharmacy Practice

Objectives:

1.        Define Key Performance Indicators (KPIs) in Pharmacy Practice

2.        Discuss the Evolution of KPIs in Pharmacy

3.        Demonstrate Practical Implementation of KPIs in Pharmacy Settings

4.        Evaluate Challenges and Opportunities in KPI Implementation

Jennifer Twilla, PharmD, BCPS, FCCP

Director of Pharmacy

Assistant Professor UTHSC College of Pharmacy

Methodist University Hospital

9:00-10:00am

1

PO Or No-Go? The Great Staph Step-Down Showdown

Objectives:

1.        Define the criteria for uncomplicated vs complicated S. aureus bacteremia

2.        Evaluate the current literature pertaining to treatment of S. aureus bacteremia

3.        Apply current literature to patient scenario to develop treatment plan for patient with S. aureus bacteremia

Tyler Martin, PharmD

Antimicrobial Stewardship Pharmacist

Archbold Medical Center

Rachel Musgrove, PharmD, BCIDP

Clinical Pharmacy Specialist - Infectious Diseases

St. Joseph's/Candler Health System

10:00am-10:15am

10:15-11:15 am

1

 Utilization of Collaborative Teams to Advance Pharmacy Practice

Objectives:

1.        Discuss how to create and optimize collaborative pharmacy teams to reach mutual goals and aspirations

2.        Describe how collaborative teams can be utilized to advance pharmacy practice across a variety of settings

3.        Apply the strategies discussed to build collaborative teams that may be able to improve relevant pharmacy practice needs 

Devin Lavender, PharmD, BCPS, BCACP

Clinical Assistant Professor

Director, PGY2 Ambulatory Care Residency

UGA College of Pharmacy

CARE Center - Director of Clinical Pharmacy

Chelsea Keedy, PharmD, BCACP

Clinical Assistant Professor

UGA College of Pharmacy

PGY2 Ambulatory Care Residency Program Director & Clinical Pharmacy Specialist

St. Joseph's/Candler Health System

11:15pm-12:30 pm

Lunch Presentation

Control with confidence: Management of North American Pit Viper Envenomation

Sponsored by BTG

Valeria Perez, PharmD, BCCCP

12:30-1:30 pm

Track A

1

Brain Death Determination Guidelines: What's Changed? What's New?

Objectives:

1.        Describe the key changes in the most recent brain death determination guidelines and explain their clinical rationale

2.        Identify the necessary prerequisites and confounders that must be addressed prior to initiating a brain death evaluation

3.        Apply the updated protocol to perform a complete and compliant brain death examination, including neurologic and apnea testing, across diverse clinical scenarios

4.        Evaluate situations requiring ancillary testing and distinguish between appropriate and inappropriate use based on current guidelines

Erika J. Sigman, MD, RPNI

Assistant Professor of Neurology & Neurosurgery

Emory University School of Medicine

Grady Memorial Health

12:30-1:30 pm 

Track B

1

Updates from the Board of Pharmacy and Georgia Drugs and Narcotics Agency

1.         Describe the History of the Georgia Board of Pharmacy (BOP) and Georgia Drugs and Narcotics Agency (GDNA) 

2.         Discuss common cases brought before the BOP.

3. Review common types of GDNA inspections and complaints received by GDNA. 

Michael Brinson, R.PH.

President of the Georgia Board of Pharmacy

Clint Joiner
Executive Director, Georgia Board of Pharmacy & Dentistry

Michael Karnbach, PharmD
Director, GDNA

Tommy Roe, PharmD
Special Agent, GDNA

1:30pm-1:45pm

1:45-2:45 pm

1

340B Drug Discount Program: Hot Topics and Practice Pointers

Objectives:

1. Review recent developments in the 340B Program, including federal and state litigation and federal and state legislation updates
2.    Identify changes to 340B Program operations and practice in response to manufacturer actions, litigation and policy updates, including approaches to key program definitions such as eligible patient definition and eligible location and new contract pharmacy replenishment models
3.    Review recent regulatory and positional changes by HRSA
4.    Review 340B operational best practices, including policies and procedures and avoidance of diversion and duplicate discount

Leah D’Aurora Richardson

Partner

Foley & Lardner LLP

Kristin Fox-Smith
Managing Director, Hospital and Health Systems

Visante

2:45-3:45 pm

Track A

1

Become familiar with your friendly neighborhood BIOSIM-ilar (series, part 2)

Objectives:

1.        Review the pharmacology and FDA approval process of a biosimilar

2.        Discuss the current landscape of biosimilars in clinical practice

3.        Examine the financial benefit of utilizing biosimilars in practice

4.    Outline the key considerations when preparing to utilize biosimilars

Kalu Kalu, PharmD

Manager, Ambulatory Infusion

Pharmaceutical Services

Winship Cancer Institute

2:45-3:45 pm 

Track B

1

Copay Maximizers: Understanding the Impact on Medication Access

Objectives:

1.        Examine financial toxicity in healthcare

2.        Define medication access and describe medication access options

3.        Define copay maximizer and accumulator programs

4.        Describe the impact copay maximizer and accumulator programs have on patients and  health systems

Regina Edmonds, EdD, MBA, BCPA, CPhT, SHRM-CP

Pharmacy Manager-Medication Access

Wellstar MCG Health

Lauren Shaffstall, MPH, CPhT

Pharmacy Reimbursement Coordinator

Atrium Health

3:45-4:00 pm

4:00-5:00pm

Officer Installation and Awards

5:00- 7:00 pm

RECEPTION/EXHIBITS

Saturday, July 12, 2025

7:30-8:30 am 

REGISTRATION/BREAKFAST 

7:30-9:30 am 

Reverse Expo

8:30-9:30 am

1

Infectious Disease/Internal Medicine Jeopardy

1. Recognize guideline directed therapy and monitoring for select disease states

2.  Identify key laboratory values for selecting optimal therapies and monitoring

3.  Distinguish mechanisms of action, safety profile and monitoring parameters for common pharmacotherapy agents

Bruce M Jones, PharmD, FIDSA, BCPS

Moderator:  Dustin Orvin

9:30-10:55 am

Break and Exhibits

   (1.5 hours)

11:00-12:00 pm

1

IASHP Keynote-Maximizing Opportunities to Build Resiliency

Objectives:

1. Describe the significance of the contributions that leaders like Harvey AK Whitney and Bernie Mehl have made to the profession

2. Identify specific activities that can build resilience

3. Examine how failure can increase growth and capacity for resilience

Leigh Briscoe Dwyer, PharmD, BSPharm, FASHP

ASHP President

System Director of Pharmacy

UHS Hospitals System

12:00-1:00pm 

Track A

1

 Staying Calm in the Chaos: Optimizing Sedation Strategies for the Critically Ill

Objectives:

1. Identify commonly used sedative agents and describe their mechanisms of action and key parameters relevant to critical care.

2. Assess patient-specific factors influencing sedative selection, including organ dysfunction, hemodynamic status, and risk for delirium.

3. Interpret and apply guideline-based recommendations for sedation management in mechanically ventilated and critically ill patients.

4. Formulate evidence-based, pharmacist-driven interventions to optimize sedation regimens and improve patient outcomes in the ICU.

Stephen McCall, PharmD, BCPS, BCCCP

Clinical Pharmacy Specialist – Emergency Medicine

St. Joseph’s/Candler Health System

Assistant Professor of Pharmacy Practice

12:00-1:00pm 

Track B

1

Neonatal Respiratory Diseases

Objectives:

1.    Describe the types of respiratory diseases in neonates focusing on respiratory distress syndrome and transient tachypnea of the newborn
2.    Compare the etiology and pathophysiology of respiratory distress syndrome and transient tachypnea of the newborn
3.    Apply the use of corticosteroids in perinatal management of respiratory distress syndrome 
4.    Assess surfactant therapy in respiratory distress syndrome
5.    Discuss the management of transient tachypnea of the newborn 

Tabitha Carney, PharmD, MBA, MSHA, BCPS

Clinical Pharmacy Specialist--Pediatrics/Neonatology

PGY1 Pharmacy Residency Program Director

Emory Healthcare

12:00-2:00pm 

1

Resident and Student Forum

Sunday, July 13, 2025

7:30-8:00 am 

REGISTRATION/BREAKFAST 

8:00-9:00am 

1

Practitioner Clinical Pearls 

Objectives:

1.        Discuss contemporary issues in pharmacy practice that have been researched and presented by pharmacy residents, fellows, and graduate students

2.        Compare and contrast completed research, research in progress, and special projects conducted to investigate solutions and improvements to contemporary issues in pharmacy practice

3.        Exchange professional information and ideas with colleagues

4.        Discuss issues confronting institutional and community-based practice

5.        Develop and nurture inter-professional relationships

6.         Apply leadership skills among current and future pharmacy practitioners

7.        Participate in an atmosphere that encourages professional network support among conference participants

Matthew Hurd, PharmD, MS

Pharmacy Manager

Emory Healthcare

Mike Melroy, PharmD, MHA, BCPS, FASHP

Director of Pharmacy

St. Joseph’s/Candler Health System

Nirali Naik, PharmD, BCEMP

Clinical Pharmacy Specialist – Burn Critical Care/EM

Wellstar Cobb Hospital

Cindy Nee, PharmD

Medication Adherence Pharmacist

Grady Health System

Ashley Woodhouse, PharmD, BCACP, CDTM

Clinical Quality Coordinator

PGY2 Ambulatory Care Residency Program Coordinator

St. Joseph’s/Candler Physician Network

9:00-10:00am 

Track A

1

Pharmacogenomics: Using DNA to Personalize Drug Therapy

Objectives:

1.        Define pharmacogenomics (PGx) and provide a brief history of the field

2.        Discuss the evidence base for PGx

3.        Discuss the role of the pharmacist in PGx

4.        Apply the role of a pharmacist to various PGx case studies.

Jennifer Marquez, PharmD, BCOP

Hematology/Oncology Clinical Pharmacist

John B. Amos Cancer Center – Piedmont Healthcare

Pharmacogenomics Consultant

Founder/CEO, PharmDNA, LLC

9:00-10:00am 

Track B

1

 Refeeding Syndrome: So Nutritious, It's Suspicious

Objectives:

1.     Describe the pathophysiology and clinical presentation of refeeding syndrome (RFS)

2.        Discuss the importance of screening patients at risk of RFS

3.   Apply clinical knowledge on RFS to a patient case

Rachel Leong, Pharm.D., BCNSP

Clinical Pharmacy Specialist- Nutrition Support​

Nutrition Support Pharmacy Fellowship Coordinator

Emory University Hospital

10:15-11:15am

1

Understanding Quality Driven Health-System Pharmacy

Objectives:

1.        Introduce pharmacy strategy and enterprise as it applies to quality care

2.        Compare quality improvement methodologies that are commonly encountered in health system pharmacy

3.        Examine national standards and quality improvement measures that influence pharmacy departments

4.        Demonstrate the application of a quality improvement method to a quality measure

Derek Gaul, PharmD, MBA, BCPS

Clinical Pharmacy Specialist

St. Joseph’s/Candler Health System

Dustin Orvin, PharmD, BCPS

Pharmacy Clinical Coordinator

St. Joseph’s/Candler Health System